AXP
62
5
PRU
45
5
PSA
43
3
PPL
49
2
EQT
33
-4
ORLY
43
4
C
51
5
V
58
2
CCL
46
-4
QCOM
52
4
HIG
46
2
ACN
45
-2
XYL
25
2
HBAN
54
3
NWS
58
2
GOOG
67
2
EMC
36
9
DLTR
52
-8
MDLZ
26
2
FMC
33
11
AXP
62
5
PRU
45
5
PSA
43
3
PPL
49
2
EQT
33
-4
ORLY
43
4
C
51
5
V
58
2
CCL
46
-4
QCOM
52
4
HIG
46
2
ACN
45
-2
XYL
25
2
HBAN
54
3
NWS
58
2
GOOG
67
2
EMC
36
9
DLTR
52
-8
MDLZ
26
2
FMC
33
11
Financhill
Back

Humacyte Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52

HUMA
Humacyte

Last Price:
$5.10
Seasonality Move:
14.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Dreams, Mode Mobile Delivers

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Humacyte Stock Forecast

  • Over the next 52 weeks, Humacyte has on average historically risen by 3.1% based on the past 4 years of stock performance.
  • Humacyte has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Humacyte Stock Undervalued?
    The current Humacyte [HUMA] share price is $5.10. The Score for HUMA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • HUMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Humacyte Stock Go Up Next Year?

  • Over the next 52 weeks, Humacyte has on average historically risen by 3.1% based on the past 4 years of stock performance.

Humacyte Stock Rating

Buy
52
Humacyte (HUMA) is a Buy

Is Humacyte overpriced?

  • Humacyte has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Humacyte Stock Price History

Is HUMA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HUMA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
humacyte.com

52-Week Data

52-Week High:
9.97
52-Week Low:
2.48

Prediction Charts

Market Cap:
656.2M
Price in USD:
5.10
Volume:
3.9M
Beta:
1.34

Technical Analysis

SMA50:
4.79
SMA100:
5.26
SMA200:
5.50
52-Wk Change:
91.01%

Stock Predictions

  • Is Humacyte stock public?
    Yes, Humacyte is a publicly traded company.
  • What is the Humacyte stock quote today?
    The Humacyte stock price is 5.10 USD today.
  • How to buy Humacyte stock online?
    You can buy Humacyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 4.12 4.10 4.22 4.01
Dec-16 4.10 4.34 4.35 4.08
Dec-17 4.30 3.80 4.42 3.56
Dec-18 3.85 3.54 3.86 3.51
Dec-19 3.52 3.46 3.66 3.37
Dec-20 5.78 4.64 6.77 4.45
Dec-23 4.90 4.65 4.97 4.16
Dec-24 4.66 4.51 4.70 4.43
Dec-26 4.50 5.29 5.30 4.40
Dec-27 5.38 5.50 5.66 5.13
Dec-30 5.35 5.09 5.47 5.03
Dec-31 5.19 5.05 5.19 4.86
Jan-2 5.02 5.18 5.48 4.93
Jan-3 5.13 5.10 5.25 5.01

Humacyte Earnings

Humacyte Earnings Report: Per Share Humacyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Humacyte Forecast Revenue Growth

Humacyte Stock Analysis: Historical quarterly revenues per share for Humacyte and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.82 per share.

* Humacyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.